Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg
A
A
Department of General and Visceral Surgery, Friedrich-Schiller University, Jena, Germany.
Grube
T
T
Hommann
M
M
Schotte
U
U
Scheele
J
J
D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D010750:Phosphoproteins / Q000097:blood; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D014763:Viral Matrix Proteins / Q000097:blood
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa; D015774:Ganciclovir; D008775:Methylprednisolone